London Genetics Focuses on Partnering Following Successful Pharmacogenetics ...(he conferencecovering topics such as imp...),Health

Dominique Kleyn, CEO, commented 'Following on from our successful inaugural conference, London Genetics is building on the raised profile of pharmacogenetics in drug development with an intensive partnering programme. By working with us throughout the drug development process biopharmaceutical companies will gain the value of the pharmacogenetics expertise they need to increase productivity, as well as drug safety, efficacy and cost-effectiveness. Recent deals in the sector provide evidence of the growing enthusiasm in this area and London Genetics is offering practical and concrete support to help companies realise value from it'.

1 London Genetics Limited Pharmacogenetics Conference - Harnessing Genetic Knowledge To Improve Clinical Development and Patient Care, 23rd - 24th September 2009, Tylney Hall, Hampshire, UK

2 BIO-Europe 2009, November 2 - 4 2009, Vienna, Austria

http://www.ebdgroup.com/bioeurope/

3 The Burrill Personalized Medicine Meeting, November 9-10 2009, San Francisco, USA

http://www.burrillandco.com/personalized_medicine_2009/

4 International Congress on Genetics and Genomics at the American Heart Association, November 14-18 2009, Orlando, USA

http://scientificsessions.americanheart.org/portal/scientificsessions/ss/

icgg2009

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

    5 Genesis 2009, December 10-11
'/>"/>
SOURCE  London Genetics Ltd
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 
Related medicine technology :

1. PRA International: Participating Sponsor for Exploratory Clinical Development World in London
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Genetics Determine Optimal Drug Dose of Common Anticoagulant
5. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
6. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
7. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
8. ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R)
9. deCODE Obesity Study Sheds Light on How Genetics Affects Risk and Onset of Common Diseases
10. Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
11. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test